166 related articles for article (PubMed ID: 33919582)
21. Delivery of Docetaxel to Brain Employing Piperine-Tagged PLGA-Aspartic Acid Polymeric Micelles: Improved Cytotoxic and Pharmacokinetic Profiles.
Singh A; Thotakura N; Singh B; Lohan S; Negi P; Chitkara D; Raza K
AAPS PharmSciTech; 2019 Jun; 20(6):220. PubMed ID: 31201588
[TBL] [Abstract][Full Text] [Related]
22. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug.
Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T
Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244
[TBL] [Abstract][Full Text] [Related]
23. Fabrication of fucoxanthin/2-hydroxypropyl-β-cyclodextrin inclusion complex assisted by ultrasound procedure to enhance aqueous solubility, stability and antitumor effect of fucoxanthin.
Sun X; Zhu J; Liu C; Wang D; Wang CY
Ultrason Sonochem; 2022 Nov; 90():106215. PubMed ID: 36356498
[TBL] [Abstract][Full Text] [Related]
24. Hot melt extrusion as an approach to improve solubility, permeability and oral absorption of a psychoactive natural product, piperine.
Ashour EA; Majumdar S; Alsheteli A; Alshehri S; Alsulays B; Feng X; Gryczke A; Kolter K; Langley N; Repka MA
J Pharm Pharmacol; 2016 Aug; 68(8):989-98. PubMed ID: 27283755
[TBL] [Abstract][Full Text] [Related]
25. Piperine: bioactivities and structural modifications.
Qu H; Lv M; Xu H
Mini Rev Med Chem; 2015; 15(2):145-56. PubMed ID: 25553428
[TBL] [Abstract][Full Text] [Related]
26. Electrochemical behaviour of piperine. Comparison with control antioxidants.
Carp OE; Moraru A; Pinteala M; Arvinte A
Food Chem; 2021 Mar; 339():128110. PubMed ID: 33152887
[TBL] [Abstract][Full Text] [Related]
27. Preparation and Properties of Cyclodextrin Inclusion Complexes of
Zhang X; Su J; Wang X; Wang X; Liu R; Fu X; Li Y; Xue J; Li X; Zhang R; Chu X
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566111
[TBL] [Abstract][Full Text] [Related]
28. Piperine: Old Spice and New Nutraceutical?
Smilkov K; Ackova DG; Cvetkovski A; Ruskovska T; Vidovic B; Atalay M
Curr Pharm Des; 2019; 25(15):1729-1739. PubMed ID: 31267856
[TBL] [Abstract][Full Text] [Related]
29. In vitro blood-brain barrier permeability predictions for GABAA receptor modulating piperine analogs.
Eigenmann DE; Dürig C; Jähne EA; Smieško M; Culot M; Gosselet F; Cecchelli R; Helms HCC; Brodin B; Wimmer L; Mihovilovic MD; Hamburger M; Oufir M
Eur J Pharm Biopharm; 2016 Jun; 103():118-126. PubMed ID: 27018328
[TBL] [Abstract][Full Text] [Related]
30. Formulation of Piperine-Chitosan-Coated Liposomes: Characterization and In Vitro Cytotoxic Evaluation.
Imam SS; Alshehri S; Altamimi MA; Hussain A; Qamar W; Gilani SJ; Zafar A; Alruwaili NK; Alanazi S; Almutairy BK
Molecules; 2021 May; 26(11):. PubMed ID: 34072306
[TBL] [Abstract][Full Text] [Related]
31. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
Cherniakov I; Izgelov D; Domb AJ; Hoffman A
Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128
[TBL] [Abstract][Full Text] [Related]
32. Quantum Chemical and Docking Insights into Bioavailability Enhancement of Curcumin by Piperine in Pepper.
Patil VM; Das S; Balasubramanian K
J Phys Chem A; 2016 May; 120(20):3643-53. PubMed ID: 27111639
[TBL] [Abstract][Full Text] [Related]
33. Ternary system of dihydroartemisinin with hydroxypropyl-β-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions.
Wang D; Li H; Gu J; Guo T; Yang S; Guo Z; Zhang X; Zhu W; Zhang J
J Pharm Biomed Anal; 2013 Sep; 83():141-8. PubMed ID: 23732534
[TBL] [Abstract][Full Text] [Related]
34. Inclusion complex of ITH12674 with 2-hydroxypropyl-β-cyclodextrin: Preparation, physical characterization and pharmacological effect.
Michalska P; Wojnicz A; Ruiz-Nuño A; Abril S; Buendia I; León R
Carbohydr Polym; 2017 Feb; 157():94-104. PubMed ID: 27988012
[TBL] [Abstract][Full Text] [Related]
35. Development of core-shell nanocarrier system for augmenting piperine cytotoxic activity against human brain cancer cell line.
Sedeky AS; Khalil IA; Hefnawy A; El-Sherbiny IM
Eur J Pharm Sci; 2018 Jun; 118():103-112. PubMed ID: 29597041
[TBL] [Abstract][Full Text] [Related]
36. Preparation and characterisation of ecdysterone/hydroxypropyl-Β-cyclodextrin inclusion complex with enhanced oral and transdermal bioavailability.
Wang L; Li S; Cai H; Liu X; Feng T; Zhao X
J Microencapsul; 2022 Mar; 39(2):145-155. PubMed ID: 35311602
[TBL] [Abstract][Full Text] [Related]
37. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
Sherje A; Londhe V
Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxicity and comparative binding mechanism of piperine with human serum albumin and α-1-acid glycoprotein.
Yeggoni DP; Rachamallu A; Kallubai M; Subramanyam R
J Biomol Struct Dyn; 2015; 33(6):1336-51. PubMed ID: 25054206
[TBL] [Abstract][Full Text] [Related]
39. Natural product piperine alleviates experimental allergic encephalomyelitis in mice by targeting dihydroorotate dehydrogenase.
Liu Z; Hu Q; Wang W; Lu S; Wu D; Ze S; He J; Huang Y; Chen W; Xu Y; Lu W; Huang J
Biochem Pharmacol; 2020 Jul; 177():114000. PubMed ID: 32353424
[TBL] [Abstract][Full Text] [Related]
40. Exploring the different environments effect of piperine via combined crystallographic, QM/MM and molecular dynamics simulation study.
Saravanan K; Sivanandam M; Hunday G; Pavan MS; Kumaradhas P
J Mol Graph Model; 2019 Nov; 92():280-295. PubMed ID: 31425905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
